Shares of Vericel Corp. (NASDAQ:VCEL) were up 12.3% during mid-day trading on Wednesday . The company traded as high as $2.74 and last traded at $2.65, with a volume of 609,553 shares. The stock had previously closed at $2.36.

The stock has a 50 day moving average price of $2.21 and a 200 day moving average price of $2.79. The stock’s market cap is $51.66 million.

Vericel Corp. (NASDAQ:VCEL) last released its quarterly earnings data on Monday, August 8th. The company reported ($0.21) earnings per share for the quarter, missing analysts’ consensus estimates of ($0.16) by $0.05. The business had revenue of $12.80 million for the quarter, compared to the consensus estimate of $15.05 million. On average, analysts anticipate that Vericel Corp. will post ($0.91) EPS for the current fiscal year.

Vericel Corporation, formerly Aastrom Biosciences, Inc, is a commercial-stage biopharmaceutical company dedicated to the identification, development and commercialization of therapies that enable the body to repair and regenerate damaged tissues and organs to restore normal structure and function. The Company operates through the research, product development, manufacture and distribution of patient-specific, expanded cellular therapies for use in the treatment of specific diseases segment.

Get Analysts' Upgrades and Downgrades Daily - Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with's FREE daily email newsletter.